For decades, the U.S. healthcare system has been shaped around male physiology, with devastating consequences for women. A new report by Pegasus Legal Capital reveals how this male-centric bias in medicine continues to harm women’s health outcomes — particularly when it comes to misdiagnosis and undertreatment of critical conditions.
When Conditions Don’t Look the Same in Women
Many of the most common and dangerous health conditions present differently in women than in men. Yet healthcare training, clinical research, and diagnostic guidelines have historically been based on male symptoms.
- Heart Attacks: While chest pain is considered the “classic” symptom, women often experience nausea, shortness of breath, or back pain — signs that are too frequently dismissed.
- Stroke: Each year, 55,000 more women than men experience strokes, but atypical symptoms such as fatigue or hiccups delay diagnosis.
- Diabetes: Women face higher risks of complications, yet are often diagnosed later than men, limiting treatment options.
This mismatch between medical models and real-world presentation leaves women vulnerable to late or incorrect diagnoses, sometimes with life-threatening consequences.
Pain, Dismissed as “Emotional”
The report highlights another persistent barrier: a cultural bias that views women as more “emotional.” This stereotype means that women’s pain is often not taken seriously. Chronic conditions like fibromyalgia, endometriosis, and migraines are still widely under-researched and frequently misinterpreted, leading to years of delayed treatment.
One in three women report having their healthcare concerns dismissed by a provider, while nearly half feel their symptoms are not fully acknowledged.
Side Effects, Understudied and Overlooked
Between 1997 and 2000, eight widely prescribed medications were withdrawn from the U.S. market because of dangerous side effects, most of which disproportionately harmed women. Women are up to twice as likely to suffer adverse drug reactions, largely because drug trials historically excluded female participants.
Even today, women represent just 40% of clinical trial participants. Pregnant and breastfeeding women are routinely left out of research altogether, creating huge gaps in safety data.
Beyond Health: The Economic Toll
Gender bias in healthcare is not only a medical crisis but also an economic one. According to World Economic Forum data, the gender health gap costs the world 75 million years of life lost to illness or premature death each year. Closing this gap could add $1 trillion to the global economy by 2040.
Closing the Gap
Pegasus Legal Capital is calling for urgent changes, including:
- Inclusive clinical trials that reflect women of all ages and backgrounds.
- Gender-sensitive training for doctors and medical staff.
- Increased investment in female-centric research.
- A shift toward personalised medicine that recognises biological differences between men and women.
“Women’s health cannot be treated as an afterthought,” said a Pegasus spokesperson. “Our healthcare system must be rebuilt with equity at its core.”
Also Read-
- Kickstart Your Tech Career with a Diploma in Information Technology at Sigma
- 7 Risks of Ignoring Regulations in a Tech-Driven Business
- Goa Games: Spin, Win, Repeat
